Medication info

Daehan New Pharm Magnesium Chloride Injection 10%

Prescription medicationInjections
Ingredient · strength
Magnesium Chloride›100mg / 1mL
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Colorless, transparent solution contained in colorless, transparent ampules
Packaging
10mL × 10 ampules
Approval status
Active

MFDS item code 201400316 · Approved 2014.01.23

Summary

Main use
Correction of electrolyte imbalance and magnesium supplementation; treatment of torsades de pointes; prevention and treatment of preeclampsia
Who uses it
Adults · Children
Adult dosage
○ Treatment of torsade de pointes - Slowly administer magnesium 8mmol (magnesium chloride 1.6g) as an intravenous bolus (IV Bolus). Then administer a continuous infusion of magnesium at 0.012∼0.08mmol per minute (magnesium chloride 2.5∼16.5mg). ○ Treatment of acute hypokalemia accompanied by hypomagnesemia - Infuse magnesium 24∼32mmol (magnesium chloride 5∼6.5g) intravenously, together with potassium supplementation over 24 hours each day. (When supplementing potassium, prepare it in a container separate from this solution.) Discontinue treatment when the magnesium level returns to normal. ○ Magnesium supplementation for electrolyte imbalance and during parenteral nutrition - Infuse magnesium 6∼8mmol (magnesium chloride 1.2∼1.6g) intravenously over 24 hours. ○ Prevention and treatment of the risk of pre-eclampsia (toxemia of pregnancy) - Administer by slow intravenous injection. To treat or prevent pre-eclampsia, infuse magnesium 16mmol (magnesium chloride 3.25g) intravenously over 20∼30 minutes. If pre-eclampsia persists, repeat the intravenous infusion of magnesium 16mmol (magnesium chloride 3.25g), ensuring that the maximum cumulative amount during the first hour of treatment does not exceed magnesium 32mmol (magnesium chloride 6.5g). Continue intravenous infusion of magnesium 8∼12mmol per hour (magnesium chloride 1.5∼2.0g) for 24 hours after the last intervention. ○ In adults in general, intravenous infusion must never exceed 120mg per minute (0.6mmol per minute) to avoid potentially life-threatening hypermagnesemia.
Children's dosage
The usual dosage for children is 0.1∼0.3 mmol of magnesium per kg (magnesium chloride 20∼60mg) over 24 hours.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Correction of electrolyte imbalance and magnesium supplementation; treatment of torsades de pointes; prevention and treatment of preeclampsia

  • Torsades de Pointes
  • hypomagnesemia
  • acute hypokalemia
  • electrolyte imbalance
  • eclampsia
View approved original text

This medication is used for the treatment of a cardiac arrhythmia known as Torsades de Pointes and helps improve acute hypokalemia associated with hypomagnesemia. Additionally, it supplements magnesium to maintain body balance during electrolyte imbalances. It is also used for magnesium supplementation in patients requiring parenteral nutrition and is effective in preventing and treating eclampsia (pregnancy-induced hypertension) during pregnancy. Due to these efficacies, it is widely used in managing heart health and pregnancy-related complications.

Dosage and Administration

Adult dosage

○ Treatment of torsade de pointes - Slowly administer magnesium 8mmol (magnesium chloride 1.6g) as an intravenous bolus (IV Bolus). Then administer a continuous infusion of magnesium at 0.012∼0.08mmol per minute (magnesium chloride 2.5∼16.5mg). ○ Treatment of acute hypokalemia accompanied by hypomagnesemia - Infuse magnesium 24∼32mmol (magnesium chloride 5∼6.5g) intravenously, together with potassium supplementation over 24 hours each day. (When supplementing potassium, prepare it in a container separate from this solution.) Discontinue treatment when the magnesium level returns to normal. ○ Magnesium supplementation for electrolyte imbalance and during parenteral nutrition - Infuse magnesium 6∼8mmol (magnesium chloride 1.2∼1.6g) intravenously over 24 hours. ○ Prevention and treatment of the risk of pre-eclampsia (toxemia of pregnancy) - Administer by slow intravenous injection. To treat or prevent pre-eclampsia, infuse magnesium 16mmol (magnesium chloride 3.25g) intravenously over 20∼30 minutes. If pre-eclampsia persists, repeat the intravenous infusion of magnesium 16mmol (magnesium chloride 3.25g), ensuring that the maximum cumulative amount during the first hour of treatment does not exceed magnesium 32mmol (magnesium chloride 6.5g). Continue intravenous infusion of magnesium 8∼12mmol per hour (magnesium chloride 1.5∼2.0g) for 24 hours after the last intervention. ○ In adults in general, intravenous infusion must never exceed 120mg per minute (0.6mmol per minute) to avoid potentially life-threatening hypermagnesemia.

Children's dosage

The usual dosage for children is 0.1∼0.3 mmol of magnesium per kg (magnesium chloride 20∼60mg) over 24 hours.

Precautions

Caution is required when opening the ampule as glass fragments might enter. Special care is required, especially when used by children or elderly patients. When administering this injection, it should be done slowly, and care should be taken to avoid rapid infusion of magnesium. During injection, blood pressure, urine output, respiratory condition, and reflexes of the patient should be continuously monitored. Regular checks of magnesium levels in the blood should be performed, and treatment should be discontinued once the levels return to normal. This medication should not be used in conjunction with drugs containing calcium as they may interfere with each other's effects. Patients with poor kidney function, severe hypotension, heart failure, respiratory distress, coma, hypermagnesemia, or muscle weakness should not use this medication. Children and patients with heart diseases should take special precautions when using this medication. Pain or warmth may occur at the injection site, and rapid infusion in patients with severely impaired kidney function may result in dangerous hypermagnesemia. Caution is needed as use with certain medications may lead to increased drug concentration or heightened side effects. It should be used in pregnant women only if essential, as overdose may affect neonatal respiration. This medication can be passed through breast milk, hence, breastfeeding should be halted during treatment. In cases of overdose, symptoms such as decreased knee reflex, drowsiness, difficulty speaking, and respiratory distress may appear, with severe cases potentially leading to respiratory arrest or cardiac arrest. In cases of overdose, treatment may necessitate hydration, diuretics, artificial respiration, calcium injections, and in severe scenarios, blood dialysis. This medication is administered intravenously only for certain arrhythmias, and it should be slowly infused while the patient is lying down in a professional setting. It should be diluted with a glucose solution or normal saline, and should not be mixed with alcohol or alkaline solutions or calcium salts as precipitate may occur.

Side effects

Pain at the injection site, vascular dilation accompanied by heat sensation, hypermagnesemia, knee reflex inhibition, heat sensation, drowsiness, speech impairment, muscle paralysis causing dyspnea, respiratory arrest, cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, preferably at room temperature between 15 and 25 degrees Celsius. Storing it this way will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Colorless, transparent solution contained in colorless, transparent ampules

Package unit

10mL × 10 ampules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.